Merck operates in the areas of healthcare, life science and electronics, with around 58,000 employees in 66 countries. All three business sectors of Merck have R&D activities in Israel, and are actively promoting Sustainability in all areas.
Inter-Lab - Mercks healthcare R&D center in Yavne. Inter-Lab can be credited with a great achievement in the pharmaceutical world; the development and production of the active ingredient in Rebif, an advanced treatment for multiple sclerosis. Currently the teams are involved in the development of novel antibody-based treatments for cancer and immuno-oncology therapies.
Since 1996, Mercks biopharmaceutical sales and marketing activities in Israel are led by the team of Merck-Serono Ltd. in Herzliya.
The Life Science business of Merck is represented in Israel by the acquired Sigma-Aldrich global company. R&D, production, sales and distribution activities operate in three state-of-the-art facilities, one in Rehovot and two in Jerusalem.
Electronics R&D of semiconductor solutions is represented in Jerusalem at the Qlight site, while DS&S supplies specialty gases to Intel Kiryat Gat and other IL customers
